Citius Pharmaceuticals CEO Leonard Mazur's 2023 pay jumps 66% to $2M
Citius Pharmaceuticals reports 2023 executive compensation
By ExecPay News
Published: January 26, 2024
Citius Pharmaceuticals reported fiscal year 2023 executive compensation information on January 26, 2024.
In 2023, three executives at Citius Pharmaceuticals received on average a compensation package of $1.6M, a 53% increase compared to previous year.
Average pay of disclosed executives at Citius Pharmaceuticals
Leonard Mazur, Chief Executive Officer, received $2M in total, which increased by 66% compared to 2022. 66% of Mazur's compensation, or $1.3M, was in option awards. Mazur also received $202K in non-equity incentive plan and $475K in salary.
Myron Holubiak, Chairman, received a compensation package of $1.6M, which increased by 29% compared to previous year. 60% of the compensation package, or $953K, was in option awards.
Myron S. Czuczman, Chief Medical Officer, earned $1.2M in 2023, a 32% increase compared to previous year.
Citius Pharmaceuticals' fiscal year ends on September 30.
Related executives
You may also like
Source: SEC filing on January 26, 2024.